PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+41.14%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$224M
AUM Growth
+$224M
(+77%)
Cap. Flow
+$85.2M
Cap. Flow
% of AUM
38.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Ocular Therapeutix
OCUL
|
$85.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 78.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ocular Therapeutix
OCUL
$2.12B
| $85.2M | 38.08% |
+2,030,009
| New | +$85.2M |
|
|
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
| $36.9M | 16.46% |
2,374,571
| – | – |
|
3
Dare Bioscience
DARE
$27.2M
| $29.6M | 13.23% |
3,287,529
| – | – |
|
|
TRVN
4
DELISTED
Trevena, Inc.
TRVN
| $24.6M | 10.98% |
3,769,280
| – | – |
|
|
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
| $24.4M | 10.89% |
2,055,230
| – | – |
|
6
Fate Therapeutics
FATE
$120M
| $12.1M | 5.4% |
2,473,186
| – | – |
|
|
BIND
7
DELISTED
BIND THERAPEUTICS INC
BIND
| $11.1M | 4.95% |
2,018,253
| – | – |
|